Cargando…
Evaluating drug resistance in visceral leishmaniasis: the challenges
For decades antimonials were the drugs of choice for the treatment of visceral leishmaniasis (VL), but the recent emergence of resistance has made them redundant as first-line therapy in the endemic VL region in the Indian subcontinent. The application of other drugs has been limited due to adverse...
Autores principales: | HENDRICKX, S, GUERIN, PJ, CALJON, G, CROFT, SL, MAES, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989324/ https://www.ncbi.nlm.nih.gov/pubmed/27866478 http://dx.doi.org/10.1017/S0031182016002031 |
Ejemplares similares
-
In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates
por: Hendrickx, Sarah, et al.
Publicado: (2019) -
Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis
por: Dirkx, Laura, et al.
Publicado: (2022) -
Drug Resistance in Visceral Leishmaniasis
por: Maltezou, Helena C.
Publicado: (2010) -
Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India
por: Dial, Natalie J., et al.
Publicado: (2022) -
Innovations for the elimination and control of visceral leishmaniasis
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2019)